Inhibition of lethal factor protease activity from anthrax toxin

作者: Alex Strongin , Maurizio Pellecchia

DOI:

关键词:

摘要: The present invention provides compounds that efficiently and specifically inhibit lethal factor (LF) protease activity of anthrax toxin.

参考文章(46)
P. Hanna, Anthrax Pathogenesis and Host Response Current Topics in Microbiology and Immunology. ,vol. 225, pp. 13- 35 ,(1998) , 10.1007/978-3-642-80451-9_2
Michael A. Sturgess, Samala J. Rao, Tony Giordano, Inhibitors of RNase P proteins as antibacterial compounds ,(2002)
Mitchell S. Wortzman, Skin protective composition ,(1987)
Therese K. Schmalbach, Richard F. Borch, Treatment of damaged bone marrow and dosage units therefor ,(1989)
Rossella Pellizzari, Chantal Guidi-Rontani, Gaetano Vitale, Michèle Mock, Cesare Montecucco, Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα FEBS Letters. ,vol. 462, pp. 199- 204 ,(1999) , 10.1016/S0014-5793(99)01502-1
S. H. Leppla, Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 79, pp. 3162- 3166 ,(1982) , 10.1073/PNAS.79.10.3162
Wolfgang Jahnke, Simon Rüdisser, Mauro Zurini, Spin Label Enhanced NMR Screening Journal of the American Chemical Society. ,vol. 123, pp. 3149- 3150 ,(2001) , 10.1021/JA005836G
Kenneth A. Bradley, Jeremy Mogridge, Michael Mourez, R. John Collier, John A. T. Young, Identification of the cellular receptor for anthrax toxin. Nature. ,vol. 414, pp. 225- 229 ,(2001) , 10.1038/N35101999